[go: up one dir, main page]

CN113337562B - Method for producing rhCG by using CHO (Chinese hamster ovary) cells through high-efficiency fermentation - Google Patents

Method for producing rhCG by using CHO (Chinese hamster ovary) cells through high-efficiency fermentation Download PDF

Info

Publication number
CN113337562B
CN113337562B CN202110562698.6A CN202110562698A CN113337562B CN 113337562 B CN113337562 B CN 113337562B CN 202110562698 A CN202110562698 A CN 202110562698A CN 113337562 B CN113337562 B CN 113337562B
Authority
CN
China
Prior art keywords
fermentation
cho
cells
rhcg
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110562698.6A
Other languages
Chinese (zh)
Other versions
CN113337562A (en
Inventor
夏星辉
胡锦晶
高乃波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningbo Renjian Pharmaceutical Group Co ltd
Original Assignee
Ningbo Renjian Pharmaceutical Group Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningbo Renjian Pharmaceutical Group Co ltd filed Critical Ningbo Renjian Pharmaceutical Group Co ltd
Priority to CN202110562698.6A priority Critical patent/CN113337562B/en
Publication of CN113337562A publication Critical patent/CN113337562A/en
Application granted granted Critical
Publication of CN113337562B publication Critical patent/CN113337562B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The application provides a fed-batch culture fermentation method for expressing recombinant rhCG by using CHO cells, which comprises the steps of adding manganese chloride into a fermentation mixed culture medium, or adding hydrocortisone and sodium pyrophosphate into the fed-batch culture medium. The application also provides a corresponding culture medium for the method.

Description

Method for producing rhCG by using CHO (Chinese hamster ovary) cells through high-efficiency fermentation
Technical Field
The application belongs to the field of protein and the field of cell culture, and particularly provides a method for producing rhCG by using CHO cells through high-efficiency fermentation and a corresponding culture medium thereof.
Background
Human chorionic gonadotropin (hCG), a hormone synthesized by placental trophoblasts, consists of alpha and beta subunits, and is currently widely used for treating diseases such as female infertility, sexual dysfunction, abortion, dwarfism, skin itch, tumors and the like.
The hCG is prepared by taking urine of pregnant women as a raw material through methods such as precipitation, ion exchange chromatography and the like, contains more impurities, has uncertain sources, risks of infectious diseases, batch differences, easy occurrence of anaphylactic reaction and the like, and has risks in clinical use. Researchers have subsequently focused on the development of recombinant technology for production and have gradually replaced urinary HCG in the clinic.
Although there have been attempts to use hosts such as insect cells and nerve cells, the cell most commonly used in rhCG production is still a CHO cell. However, links such as an expression regulation mechanism of protein in CHO cells, a protein posttranslational modification regulation system, a cell growth metabolism regulation mechanism and the like are still lack of deep knowledge, so that theoretical guidance levels in aspects of exogenous gene integration strategies, screening of high-expression strains, efficient culture medium configuration, culture process regulation and the like are low, and related researches rely more on a large number of optimization screening and optimization experiments to obtain better operation conditions. The method has the advantages of low research and production efficiency, long time consumption, high cost and great influence by accidental factors. Although foreign advanced enterprises have developed Glutamine Synthetase (GS) systems, customized serum-free personalized media, optimized high-density microcarrier culture processes and feeding strategies, applied low-cost and low-shear bioreactors, high-level expression of rhCG still requires long culture times (> 20 days) and high production costs.
Therefore, there is still a need in the art for further improvements in the technology of CHO cell production of rhCG.
Disclosure of Invention
After factors such as fermentation parameters, cells and the like are optimized in the early stage, improvement of a fermentation mixed culture medium and a fed-batch culture medium is tried, the influence of various special additives on CHO expression rhCG is researched, and the fact that the expression level of the rhCG can be effectively improved by adding manganese ions, hydrocortisone and sodium pyrophosphate into the culture medium is found.
In one aspect, the present application provides a fed-batch fermentation method for expressing recombinant rhCG using CHO cells, comprising adding manganese chloride to a fermentation mixed medium, or adding hydrocortisone and sodium pyrophosphate to a feed medium.
Further, the concentration of manganese chloride added was 3mg/ml, and the concentrations of hydrocortisone and sodium pyrophosphate added were 0.05mg/ml and 3 mg/ml.
Further, the fermentation time was 12 days.
Further, the density was 1.5 x 106The cells with cells/ml above are inoculated into 50L of fermentation mixed culture medium which is pre-cultured overnight, the day of inoculation is the first day, and 10L of feed medium is added when the cells are cultured for 3 days, 6 days and 9 days.
Further, the culture parameters were: 36.5 +/-1 ℃, pH value controlled at 6.8-7.2, dissolved oxygen controlled at 20-70 percent and rotation speed controlled at 60 +/-5 revolutions per minute.
On the other hand, the application provides a culture medium for CHO cell expression recombination rhCG, which comprises a fermentation mixed culture medium and a feeding culture medium, wherein manganese chloride is added into the fermentation mixed culture medium, or hydrocortisone and sodium pyrophosphate are added into the feeding culture medium.
Further, the concentration of manganese chloride added was 3mg/ml, and the concentrations of hydrocortisone and sodium pyrophosphate added were 0.05mg/ml and 3 mg/ml.
In another aspect, the present application provides the use of manganese chloride, hydrocortisone, and/or sodium pyrophosphate in the preparation of a culture medium for recombinant rhCG expression in CHO cells.
Further, the concentration of manganese chloride in the medium was 3mg/ml, and the concentrations of hydrocortisone and sodium pyrophosphate were 0.05mg/ml and 3 mg/ml.
Drawings
FIG. 1 shows the basic process of producing rhCG by CHO cell fermentation.
FIG. 2 is a graph showing the relative abundance of each subunit of hCG at day 6 of fermentation culture.
Detailed Description
Example 1 cells, media and other reagents used for fermentation
The CHO cells used for the fermentation, made by the applicant, were transfected with vectors carrying rhCG alpha, beta subunits into CHO cell K1 strain using Lipofectamine TM2000 Lipofectase transfection reagent, which was subsequently acclimated without serum and had been used for more than 18 months in the applicant's pilot production of rhCG.
The applicant is a culture medium prepared in the fermentation process:
subculture medium:
CD CHO AGT 24.3mg/ml, dihydrogen phosphate monohydrate 2.69mg/ml, disodium hydrogen phosphate 4.33mg/ml, L-arginine 550mg/ml, L-asparagine 1300mg/ml, L-aspartic acid 400 mg/ml;
fermentation mixed culture medium:
24.3mg/ml of CD CHO AGT, 9.66mg/ml of CD OPTICHO AGT, 2.69mg/ml of monobasic sodium phosphate monohydrate, 4.33mg/ml of dibasic sodium phosphate, 0.15mg/ml of biotin, 11.5mg/ml of folic acid, 120mg/ml of inositol, 300mg/ml of potassium chloride, 5500mg/ml of glucose, 2100mg/ml of sodium chloride and 30mg/ml of soybean protein hydrolysate;
a supplemented medium:
balancd CHO Feee 366 mg/ml, sodium dihydrogen phosphate monohydrate 2.69mg/ml, disodium hydrogen phosphate 4.33mg/ml, L-arginine 2000mg/L, L-aspartic acid 4500mg/L, vitamin C15mg/L, vitamin H5 mg/L folic acid 30mg/L, inositol 400mg/L, vitamin B125 mg/L, potassium chloride 0.0015mg/L, F-68950 mg/L, glucose 18000 mg/L;
HCG ELISA kit: japanese Tosoh;
MnCl2: jinan Kai Chuang chemical Co., Ltd;
CD CHO AGT:gibco
CD OPTICHO AGT:gibco
BalanCD CHO Feee3:irvine scientific
sodium pyrophosphate: food grade, Shandong Guante bioengineering, Inc.;
hydrocortisone: shanghai Michelin Biochemical technology, Inc.;
other reagents and instruments including PCR reagents and instruments are all made in the conventional countries.
Example 2 basic fermentative production Process
Cell recovery:
1) and taking the cell freezing tube, and placing the tube in a water bath kettle at 37 ℃ until the frozen cell suspension is melted.
2) And (3) transferring the frozen cells to a centrifugal tube filled with 6-7 ml of CHO subculture medium, centrifuging at 1000rpm for 5 minutes, and removing the supernatant.
3) Gently blow and beat the conglomerated cells at the bottom in the centrifuge tube by using 10ml of CHO subculture medium sucked in times.
4) Inoculating into 125ml shake flask containing 10ml CHO subculture medium to obtain final volume of about 20ml, and inoculating with cell density of 0.4-1.0 x 106Individual cells/ml. Placing the shake flask in a carbon dioxide incubator at 36.5 + -1 deg.C and 5 + -3% CO2And 125. + -. 10 rpm.
Passage:
1) and (3) shake flask culture: placing the cell shake flask in a carbon dioxide incubator at 36.5 + -1 deg.C and 5 + -3% CO2And 125. + -. 10 rpm. Cell counts were performed daily when cell density reached 1.5 x 106When the cell density is above 0.4-1.0 x 10, adding CHO passage culture medium, and adjusting cell density6Individual cells/ml.
2) wave culture: when the cell density reaches 1.5 x 106Collecting cell sap in shake flask into sterile bottle, inoculating into cell culture bag via sterile tube connecting machine, and adjusting cell density to 0.4-1.0 × 106Each cell/ml, the cell culture bag was placed on a rocking apparatus at 36.5. + -. 1 ℃ and 20. + -. 5rpm for culture. When the cell density reaches 1.5 x 106When the cell density is above 0.4-1.0 x 10, adding CHO passage culture medium, and adjusting cell density6Individual cells/ml.
Fermentation: (100L scale):
when the volume is 20LCell density 1.5 x 10 in cell culture bag6When the cell/ml is more than 20L, inoculating to 50L of fermentation mixed culture medium which is pre-cultured overnight, determining the first day on the day of inoculation, and adding 10L of feeding culture medium respectively on the 3 rd, 6 th and 9 th days of culture. Culturing for 12 days, and fermenting (culture parameters: 36.5 + -1 deg.C, pH 6.8-7.2, dissolved oxygen 40-60%, and rotation speed 60 + -5 rpm).
After and during fermentation HCG levels were determined using the kit described in example 1, and alpha and beta subunit transcript levels were determined by PCR using primers of the prior art (alpha subunit: upstream CTGGTCACATTGTGCTATCTTTC, downstream TGAGGTGACGTTCTTTTGGAC; beta subunit: upstream ATGTTCCAGGGGCTGCTGCTGTT, downstream CGCGGTAGTTATTGCACCACACCACCTGA)
Example 3 optimization of the fermentation Process
Through the optimization of factors such as fermentation parameters, cells and the like in the early stage, the expression level of the recombinant protein of about 180mg/L is realized within 12 days by the method. To further increase yield/reduce costs at similar yields, we have further improved the customized media themselves. With reference to the prior art, attempts were made to add MnCl to the culture medium2(3 mg/ml added to the fermentation mix), hydrocortisone, sodium pyrophosphate, the results are as follows:
TABLE 1 optimization of the effect of manganese ion addition to cell lines and fermentation Medium mixtures on expression levels (mean of three jar samples)
Figure BDA0003079611900000041
The results of further studies on the transcript levels are shown in FIG. 2: we found that the ratio of beta subunit to alpha subunit in the optimized cell line significantly exceeded that of the original cell line, which means that alpha subunit transcriptional expression may be a yield-limiting factor in the optimized cell line, whereas MnCl was added to the fermentation mix2The transcription level of the alpha subunit can be effectively improved, and the yield is further improved;
TABLE 2 Effect of hydrocortisone and sodium pyrophosphate addition to feed medium on expression levels (optimized cell lines, three pot sample averages)
Figure BDA0003079611900000042
The addition of hydrocortisone or sodium pyrophosphate into the feed medium alone has no obvious effect on increasing the yield, while the combination of hydrocortisone and sodium pyrophosphate can realize the effect of obviously improving the expression amount of the recombinant protein (the primary molecule is that the combination of the two in the feed can inhibit the growth of cells and arrest the cell cycle to accumulate the product).
After combining manganese ions, hydrocortisone and sodium pyrophosphate, we achieved a high expression level of 280.22mg/L over a 12 day culture period.

Claims (3)

1. A fed-batch culture fermentation method for expressing recombinant rhCG by using CHO cells, which is characterized in that the density is 1.5 x 106Inoculating cells with the cell/ml or more into a fermentation mixed culture medium, determining the day after inoculation as the first day, and respectively adding a supplementary culture medium when culturing for 3 rd, 6 th and 9 th days; hydrocortisone at a concentration of 0.05mg/ml and sodium pyrophosphate at a concentration of 3mg/ml were included in the feed medium.
2. The method of claim 1, wherein the fermentation time is 12 days.
3. The method of claim 1, wherein the parameters during fermentation are: 36.5 +/-1 ℃, pH value controlled at 6.8-7.2, dissolved oxygen controlled at 20-70% and rotation speed controlled at 60 +/-5 r/min.
CN202110562698.6A 2021-05-24 2021-05-24 Method for producing rhCG by using CHO (Chinese hamster ovary) cells through high-efficiency fermentation Active CN113337562B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110562698.6A CN113337562B (en) 2021-05-24 2021-05-24 Method for producing rhCG by using CHO (Chinese hamster ovary) cells through high-efficiency fermentation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110562698.6A CN113337562B (en) 2021-05-24 2021-05-24 Method for producing rhCG by using CHO (Chinese hamster ovary) cells through high-efficiency fermentation

Publications (2)

Publication Number Publication Date
CN113337562A CN113337562A (en) 2021-09-03
CN113337562B true CN113337562B (en) 2022-06-03

Family

ID=77470997

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110562698.6A Active CN113337562B (en) 2021-05-24 2021-05-24 Method for producing rhCG by using CHO (Chinese hamster ovary) cells through high-efficiency fermentation

Country Status (1)

Country Link
CN (1) CN113337562B (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6924124B1 (en) * 2002-08-23 2005-08-02 Immunex Corporation Feeding strategies for cell culture
EP2154244B1 (en) * 2007-04-26 2017-04-12 Chugai Seiyaku Kabushiki Kaisha Cell culture method using amino acid-enriched medium
CN101633894B (en) * 2009-08-20 2010-12-01 北京芳能科技有限公司 Culture medium of euglena gracilis and open type high-density culture method
US20110052591A1 (en) * 2009-08-28 2011-03-03 Board Of Regents Of The University Of Texas System Variants of Thyroid Stimulating Hormone Beta
NO2760138T3 (en) * 2012-10-01 2018-08-04
WO2016170113A1 (en) * 2015-04-24 2016-10-27 Ferring B.V. Method of production of gonadotrophin
US10119117B2 (en) * 2016-01-28 2018-11-06 Nanogen Pharmaceutical Biotechnology Co., Ltd Universal, glycosylation enhancer, completely chemically defined medium formulation
CN111454877B (en) * 2019-01-22 2023-03-21 鲁南制药集团股份有限公司 CHO cell culture method
CN110042137B (en) * 2019-05-14 2023-02-28 上海赛迈生物科技有限公司 Method for producing human follicle-stimulating hormone by high-density perfusion culture of recombinant CHO cells, culture medium and application thereof
WO2021254296A1 (en) * 2020-06-14 2021-12-23 浙江大学 Bioactive substance composition, serum-free culture medium comprising the composition, and uses thereof

Also Published As

Publication number Publication date
CN113337562A (en) 2021-09-03

Similar Documents

Publication Publication Date Title
CN110607268B (en) A high-yielding L-valine genetically engineered bacterium and a method for producing L-valine by fermentation
EP3473725B1 (en) Fermentation technique with pichia yeast expressing recombinant protein
JP6479974B2 (en) A method to reproduce large-scale eculizumab-producing cell cultures
US20250236876A1 (en) Engineered yeast for efficient and rapid synthesis of erythritol and construction method thereof
CN114634952A (en) Method for improving erythritol yield and sugar alcohol conversion rate
CN116716348A (en) Method for improving protein expression quantity of recombinant cells
CN102021214B (en) Oxygen consumption rate-based vitamin B12 fermentation production control process
CN113337562B (en) Method for producing rhCG by using CHO (Chinese hamster ovary) cells through high-efficiency fermentation
CN111454877A (en) CHO cell culture method
CN114854659B (en) Ergothioneine production process and application thereof
KR102473375B1 (en) Recombinant microorganisms, their preparation methods and their use in the production of coenzyme Q10
CN115449499A (en) Denitrification hyphomycete and method for preparing pyrroloquinoline quinone through fermentation of same
CN114480359B (en) Method for producing psicose 3-epimerase by high-density fermentation
CN119120242A (en) Recombinant Pichia pastoris strain producing astaxanthin and its construction method and application
CN1191369C (en) Process for producing adenosylmethionine by metabolic engineering bacteria
CN117535330A (en) Recombinant escherichia coli for efficiently producing L-homoserine, construction method and application thereof
CN113667650A (en) 11 alpha-hydroxylase mutant and application thereof
WO2013058516A1 (en) Recombinant vector, recombinant yeast containing the vector, and mass-producing method of glucose oxidase using the yeast
CN114634902B (en) Culture medium and culture method for producing psicose epimerase and application of culture medium and culture method
CN1180080C (en) An improved preparation method of liver cancer mouse monoclonal antibody
CN102399845B (en) Production control process of vitamin B12 fermentation based on CO2 concentration in tail gas
Nie et al. A novel strategy on the high-cell-density cultivation of Candida utilis for the enhanced production of glutathione
CN114990138B (en) Gene, expression vector, bacterial strain and application thereof in improving cephalosporin C yield
CN116875475A (en) Yeast strain for high-yield cannabinoid synthesis precursor, construction method and application thereof
CN120310668A (en) Saccharomyces cerevisiae engineered bacteria for producing S-adenosylmethionine and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant